Thyroid hormone transporters and resistance

Endocrine Development

Volumn 24, Issue , 2013, Pages 1-10

  Visser, Theo J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 10; MONOCARBOXYLATE TRANSPORTER 8; THYROID HORMONE; UNCLASSIFIED DRUG; AMINO ACID TRANSPORTER; SLC16A10 PROTEIN, HUMAN; SLC16A2 PROTEIN, HUMAN; THYROID HORMONE RECEPTOR;

ARTICLE; BIOLOGICAL ACTIVITY; DELETION MUTANT; FRAMESHIFT MUTATION; GENETIC CODE; HUMAN; LIOTHYRONINE BLOOD LEVEL; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; THYROID HORMONE RESISTANCE; AMINO ACID SEQUENCE; BIOLOGICAL MODEL; GENETICS; MALE; METABOLISM; MOLECULAR GENETICS; MUSCLE ATROPHY; MUSCLE HYPOTONIA; PHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL; X LINKED MENTAL RETARDATION;

AMINO ACID SEQUENCE; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; BIOLOGICAL TRANSPORT; HUMANS; MALE; MENTAL RETARDATION, X-LINKED; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE HYPOTONIA; MUSCULAR ATROPHY; RECEPTORS, THYROID HORMONE; THYROID HORMONE RESISTANCE SYNDROME; THYROID HORMONES;

MLCS; MLOWN;

EID: 84925815396     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000343695     Document Type: Article

References (52)

1. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeold A, Bianco AC: Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 2008;29:898-938.
2. Cheng SY, Leonard JL, Davis PJ: Molecular aspects of thyroid hormone actions. Endocr Rev 2010;31: 139-170.
3. Nunez J, Celi FS, Ng L, Forrest D: Multigenic control of thyroid hormone functions in the nervous system. Mol Cell Endocrinol 2008;287:1-12.
4. Yen PM: Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001;81: 1097-1142.
5. Wojcicka A, Bassett JH, Williams GR: Mechanisms of action of thyroid hormones in the skeleton. Biochim Biophys Acta 2012, Epub ahead of print.
6. Bernal J: Thyroid hormone transport in developing brain. Curr Opin Endocrinol Diabetes Obes 2011; 18:295-299.
7. Heuer H: The importance of thyroid hormone transporters for brain development and function. Best Pract Res 2007;21:265-276.
8. Schweizer U, Kohrle J: Function of thyroid hormone transporters in the central nervous system. Biochim Biophys Acta 2012, Epub ahead of print.
9. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ: Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 2001;22:451-476.
10. Visser WE, Friesema EC, Visser TJ: Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol (Baltimore) 2011;25: 1-14.
11. Heuer H, Visser TJ: Minireview: pathophysio logical importance of thyroid hormone transporters. Endo crinology 2009;150:1078-1083.
12. Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, Meier PJ: Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol (Baltimore) 2002;16:2283-2296.
13. Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N: Expression of the thyroid hormone transporters MCT8 (SLC16A2) and OATP14 (SLCO1C1) at the blood-brain barrier. Endocrinology 2008;149:6251-6261.
14. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ: Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 2003;278: 40128-40135.
15. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ: Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol (Baltimore) 2008;22:1357-1369.
16. Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH: Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol Endocrinol (Baltimore) 2006;20:2761-2772.
17. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S: A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004;74:168-175.
18. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP, Visser TJ: Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004;364:1435-1437.
19. Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ, Stevenson RE: Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 2005; 77:41-53.
20. Vaurs-Barriere C, Deville M, Sarret C, Giraud G, Des Portes V, Prats-Vinas JM, De Michele G, Dan B, Brady AF, Boespflug-Tanguy O, Touraine R: Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects. Ann Neurol 2009; 65:114-118.
21. Halestrap AP, Meredith D: The SLC16 gene familyfrom monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 2004;447:619-628.
22. Murakami Y, Kohyama N, Kobayashi Y, Ohbayashi M, Ohtani H, Sawada Y, Yamamoto T: Functional characterization of human monocarboxylate transporter 6 (SLC16A5). Drug metabolism and disposition: the biological fate of chemicals 2005;33: 1845-1851.
23. Hugo SE, Cruz-Garcia L, Karanth S, Anderson RM, Stainier DY, Schlegel A: A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev 2012;26:282-293.
24. Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, Prehn C, Altmaier E, Kastenmuller G, Kato BS, Mewes HW, Meitinger T, de Angelis MH, Kronenberg F, Soranzo N, Wichmann HE, Spector TD, Adamski J, Suhre K: A genome-wide perspective of genetic variation in human metabolism. Nat Genet 2010;42:137-141.
25. Kolz M, Johnson T, Sanna S, et al: Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009;5:e1000504.
26. Castorino JJ, Gallagher-Colombo SM, Levin AV, Fitzgerald PG, Polishook J, Kloeckener-Gruissem B, Ostertag E, Philp NJ: Juvenile cataract-associated mutation of solute carrier SLC16A12 impairs trafficking of the protein to the plasma membrane. Invest Ophthalmol Vis Sci 2012;52:6774-6784.
27. Kloeckener-Gruissem B, Vandekerckhove K, Nurnberg G, Neidhardt J, Zeitz C, Nurnberg P, Schipper I, Berger W: Mutation of solute carrier SLC16A12 associates with a syndrome combining juvenile cataract with microcornea and renal glucosuria. Am J Hum Genet 2008;82:772-779.
28. Kim DK, Kanai Y, Chairoungdua A, Matsuo H, Cha SH, Endou H: Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters. J Biol Chem 2001;276:17221-17228.
29. Nishimura M, Naito S: Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab Pharmacokinet 2008;23:22-44.
30. Allan W, Herndon CN, Dudley FC: Some examples of the inheritance of mental deficiency: apparently sex-linked idiocy and microcephaly. Am J Mental Defic 1944;48:325-334.
31. Holden KR, Zuniga OF, May MM, Su H, Molinero MR, Rogers RC, Schwartz CE: X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype. J Child Neurol 2005;20:852-857.
32. Bernal J: Thyroid hormone receptors in brain development and function. Nat Clin Pract 2007;3: 249-259.
33. Friesema EC, Visser WE, Visser TJ: Genetics and phenomics of thyroid hormone transport by MCT8. Mol Cell Endocrinol 2010;322:107-113.
34. Jansen J, Friesema EC, Kester MH, Milici C, Reeser M, Gruters A, Barrett TG, Mancilla EE, Svensson J, Wemeau JL, Busi da Silva Canalli MH, Lundgren J, McEntagart ME, Hopper N, Arts WF, Visser TJ: Functional analysis of monocarboxylate transporter 8 mutations identified in patients with x-linked psychomotor retardation and elevated serum triiodothyronine. J Clin Endocrinol Metab 2007;92: 2378-2381.
35. Jansen J, Friesema EC, Kester MH, Schwartz CE, Visser TJ: Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8. Endocrinology 2008;149:2184-2190.
36. Kinne A, Roth S, Biebermann H, Koehrle J, Gruters A, Schweizer U: Surface translocation and T3 uptake of mutant MCT8 proteins are cell typedependent. J Mol Endocrinol 2009;43:263-271.
37. Visser WE, Philp NJ, van Dijk TB, Klootwijk W, Friesema EC, Jansen J, Beesley PW, Ianculescu AG, Visser TJ: Evidence for a homodimeric structure of human monocarboxylate transporter 8. Endocrinology 2009;150:5163-5170.
38. Friesema EC, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ: Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. Nat Clin Pract 2006;2:512-523.
39. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S: Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 2006;147: 4036-4043.
40. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K, Heuer H: Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 2007;117:627-635.
41. Wirth EK, Roth S, Blechschmidt C, Holter SM, Becker L, Racz I, Zimmer A, Klopstock T, Gailus-Durner V, Fuchs H, Wurst W, Naumann T, Brauer A, de Angelis MH, Kohrle J, Gruters A, Schweizer U: Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neurosci 2009; 29:9439-9449.
42. Trajkovic M, Visser TJ, Darras WM, Friesema ECH, Schlott B, Mittag J, Bauer K, Heuer H: Consequences of MCT8 deficiency for renal transport and metabolism of thyroid hormones in mice. Endocrinology 2009;151:802-809.
43. Di Cosmo C, Liao XH, Dumitrescu AM, Philp NJ, Weiss RE, Refetoff S: Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion. J Clin Invest 2010;120:3377-3388.
44. Trajkovic-Arsic M, Müller J, Darras VM, Groba C, Lee S, Weih D, Bauer K, Visser TJ, Heuer H: Impact of monocarboxylate transporter (Mct)-8 deficiency on the hypothalamus-pituitary-thyroid axis in mice. Endocrinology 2010;151:5053-5062.
45. Alkemade A, Friesema EC, Kalsbeek A, Swaab DF, Visser TJ, Fliers E: Expression of thyroid hormone transporters in the human hypothalamus. J Clin Endocrinol Metab 2011;96:E967-E971.
46. Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, Bauer K: The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 2005;146: 1701-1706.
47. Refetoff S, Dumitrescu AM: Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res 2007;21:277-305.
48. Yen PM: Molecular basis of resistance to thyroid hormone. Trends Endocrinol Metab 2003;14:327-333.
49. Vennstrom B, Mittag J, Wallis K: Severe psychomotor and metabolic damages caused by a mutant thyroid hormone receptor alpha 1 in mice: can patients with a similar mutation be found and treated? Acta Paediatr 2008;97:1605-1610.
50. Bochukova E, Schoenmakers N, Agostini M, et al: A mutation in the thyroid hormone receptor alpha gene. N Engl J Med 2012;366:243-249.
51. van Mullem A, van Heerebeek R, Chrysis D, Visser E, Medici M, Andrikoula M, Tsatsoulis A, Peeters R, Visser TJ: Clinical phenotype and mutant TRalpha1. N Engl J Med 2012;366:1451-1453.
52. Barca-Mayo O, Liao XH, Alonso M, Di Cosmo C, Hernandez A, Refetoff S, Weiss RE: Thyroid hormone receptor alpha and regulation of type 3 deiodinase. Mol Endocrinol (Baltimore) 2011;25: 575-583.